Skip to content
Pipamperone
Pipamperone is a small molecule pharmaceutical. It is currently being investigated in clinical studies. It is known to target histamine H1 receptor, 5-hydroxytryptamine receptor 1D, 5-hydroxytryptamine receptor 1A, 5-hydroxytryptamine receptor 2A, and 5-hydroxytryptamine receptor 1B.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
mental disordersD001523
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
No data
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
schizophreniaEFO_0000692D012559F20
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
N: Nervous system drugs
N05: Psycholeptics
N05A: Antipsychotics
N05AD: Butyrophenone derivatives, antipsychotics
N05AD05: Pipamperone
HCPCS
No data
Clinical
Clinical Trials
4 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
DepressionD003863F33.9112
DementiaD003704F0311
Psychophysiologic disordersD011602F45.911
SchizophreniaD012559EFO_0000692F2011
Anxiety disordersD001008EFO_0006788F41.111
Major depressive disorderD003865EFO_0003761F2211
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Psychotic disordersD011618F20.8111
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common namePIPAMPERONE
INNpipamperone
Description
Pipamperone is a member of the class of bipiperidines that is 1,4'-bipiperidine which is substituted at the 1' and 4' positions by 4-(p-fluorophenyl)-4-oxobutyl and carboxamide groups, respectively. A first generation antipsychotic, its properties are generally similar to those of haloperidol. It has a role as a first generation antipsychotic, a serotonergic antagonist and a dopaminergic antagonist. It is a monocarboxylic acid amide, an aromatic ketone, an organofluorine compound, a member of bipiperidines and a tertiary amino compound. It is a conjugate base of a pipamperone(2+).
Classification
Small molecule
Drug classantianxiety agents/neuroleptics (4'-fluoro-4-piperidinobutyrophenone derivatives)
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
NC(=O)C1(N2CCCCC2)CCN(CCCC(=O)c2ccc(F)cc2)CC1
Identifiers
PDB
CAS-ID1893-33-0
RxCUI33739
ChEMBL IDCHEMBL440294
ChEBI ID78549
PubChem CID4830
DrugBankDB09286
UNII ID5402501F0W (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
HRH1
HRH1
HTR1D
HTR1D
HTR1A
HTR1A
HTR2A
HTR2A
HTR1B
HTR1B
Organism
Homo sapiens
Gene name
HRH1
Gene synonyms
NCBI Gene ID
Protein name
histamine H1 receptor
Protein synonyms
histamine receptor, subclass H1
Uniprot ID
Mouse ortholog
Hrh1 (15465)
histamine H1 receptor (Q91XN3)
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 267 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
1,279 adverse events reported
View more details